AI516 and AI523 antibodies recognize the O-antigen of K. pneumoniae KpGE strain by western blot

Authors

DOI:

https://doi.org/10.24450/journals/abrep.2024.e1722

Abstract

The recombinant antibodies AI516 and AI523 detect by western blot the O-antigen of Klebsiella pneumoniae KpGE strain.

Introduction

Klebsiella pneumoniae is an opportunistic pathogen of concern due to the emergence of multidrug-resistant strains causing hospital-acquired pneumonia (Rice, 2008). The KpGe strain used in this study is a non-pathogenic and non-capsulated variant of K. pneumoniae (Lima et al., 2018). The outer membrane of K. pneumoniae contains lipopolysaccharides (LPS) that are composed of lipid A, an oligosaccharide core region and the O-antigen (March et al., 2013). Mutants unable to synthesize O-antigens, such as the wbbM– strain, which lacks the WbbM glycosyltransferase, fail to cause virulent infections across diverse hosts. (Guan et al., 2001; Benghezal et al., 2006). Antibodies ABCD_AI516 and ABCD_AI523 have been shown by flow cytometry to recognize the O-antigen at the surface of live KpGe cells but not on wbbM– mutant (Crespo-Yañez and Ayadi, 2022). Here, we assess the ability of these two antibodies to detect the O-antigen of the KpGe strain by western blot.

Materials & Methods

Antibodies: ABCD_AI516 (AI516) and ABCD_AI523 (AI523), antibodies (ABCD nomenclature, http://web.expasy.org/abcd/) were produced by the Geneva Antibody Facility (http://unige.ch/medecine/antibodies/) as mini-antibodies with the antigen-binding scFv portion fused to a mouse IgG Fc. The synthesized scFv sequences (GeneArt) correspond to the sequences of the variable regions of clones 9H9-H7 and G3-97 respectively, joined by a peptide linker (GGGGS)3. 9H9-H7 and G3-97 antibodies both target galactan II of the O-antigen in K. pneumoniae O1/O2 serotype (Szijártó et al., 2017). HEK293 suspension cells growing in HEK TF medium (Sartorius #861-0001), supplemented with 0.1% Pluronic F68 (Sigma #P1300), were transiently transfected with the vector coding for the scFv-Fc of each antibody. Supernatants (30 µg/mL for AI516 and 50 µg/mL for AI523) were collected after 4 days.

Antigen:K. pneumoniae KpGe WT and wbbM- strains were cultivated overnight at 37 °C in 3 mL of LB medium (Froquet et al., 2009). For the wbbM- strain, ampicillin was added to the LB medium at a final concentration of 100 µg/mL. LPS from these strains were purified using an LPS Extraction Kit according to manufacturer’s instructions (iNtRON Biotechnology #17141). Antibodies were also tested against total KpGe WT lysate. Commercial LPS from E. coli were used as control (Lipopolysaccharide from Escherichia coli Serotype O55:B5, Sigma #L-2637, 1 mg/mL).

Protocol: Samples of 10 µL each of either pure or diluted (1/3, 1/9, 1/27, 1/81) purified LPS and 10 µL of KpGe WT culture were mixed with 10 µL of non-reducing 2x sample buffer (20.6% w/v sucrose, 100 mM Tris, pH 6.8, 10 mM EDTA, 0.1% w/v bromophenol blue, 4% w/v SDS). Samples were then loaded (15 μL) and migrated (200 V, 30 min) on a 4-15% acrylamide gel (Mini-PROTEAN® TGX™ Precast Gel, Biorad #4561083) in Tris-Glycine-SDS buffer (Canvax #BR0063) and transferred to a nitrocellulose membrane using a dry transfer system for 7 min (iBlot gel transfer device, Invitrogen #IB23001). The membranes were blocked overnight at 4°C in PBS containing 0.1% (v/v) Tween20 and 6% (w/v) milk and washed three times for 5 min in PBS + 0.1% (v/v) Tween20. After the washing, the membranes were incubated with AI516 or AI523 (1 µg/mL in PBS-Tween) for 2 h, then washed three times for 5 min. The membranes were then incubated 1 h with horseradish peroxidase-coupled goat anti-mouse IgG (Biorad #170-6516, dilution 1:3000) and washed three times for 5 min in PBS-Tween. The signal was revealed by enhanced chemiluminescence (ECL) (Amersham Biosciences) using a PXi-4 gel imaging systems (Syngene).

Results and discussion

The Antibodies AI516 and AI523 specifically recognize the O-antigen of the K. pneumoniae KpGe WT strain (Kp) in both total lysate (Kp lysate) and purified LPS samples. The signal intensity decreased with dilution of purified KpGe LPS, indicating a dose-dependent response. No signal was detected with purified LPS from the KpGewbbM– strain (Kp wbbM–), confirming the specificity of AI516 and AI523 for the K. pneumoniae KpGe O-antigen in western blot analysis (Fig. 1). Furthermore, no signal was observed with LPS from E. coli O55:B5 (Ec), indicating that the tested antibodies do not recognize the O-antigen of this strain. Samples were also tested under reducing conditions and the results were indistinguishable with those observed in non-reducing conditions (data not shown).

Figure 1. AI516 and AI523 recognize the O-antigen from KpGe WT strain (Kp) by western blot in non-reducing conditions. They do not recognize purified LPS from E. coli O55.B5 (Ec) and purified LPS from KpGe wbbM- strain (Kp wbbM-).

Conflict of interest

The authors declare no conflict of interest.

References

Benghezal, M., Fauvarque, M. O., Tournebize, R., Froquet, R., Marchetti, A., Bergeret, E., Lardy, B., Klein, G., Sansonetti, P., Charette, S. J., & Cosson, P. (2006). Specific host genes required for the killing of Klebsiella bacteria by phagocytes. Cellular microbiology, 8(1), 139–148. https://doi.org/10.1111/j.1462-5822.2005.00607.x

Crespo-Yanez, X., & Ayadi, I. (2022). The AI516 and AI523 antibodies recognize the Klebsiella pneumoniae KpGe strain by flow cytometry. Antibody Reports, 5(1), e682. https://doi.org/10.24450/journals/abrep.2022.e682

Froquet, R., Lelong, E., Marchetti, A., & Cosson, P. (2009). Dictyostelium discoideum: a model host to measure bacterial virulence. Nature protocols, 4(1), 25–30. https://doi.org/10.1038/nprot.2008.212

Guan, S., Clarke, A. J., & Whitfield, C. (2001). Functional analysis of the galactosyltransferases required for biosynthesis of D-galactan I, a component of the lipopolysaccharide O1 antigen of Klebsiella pneumoniae. Journal of bacteriology, 183(11), 3318–3327. https://doi.org/10.1128/JB.183.11.3318-3327.2001

Lima, W. C., Pallone, T., Bertelli, C., Ifrid, E., Greub, G., & Cosson, P. (2018). Genome sequencing and functional characterization of the non-pathogenic Klebsiella pneumoniae KpGe bacteria. Microbes and infection, 20(5), 293–301. https://doi.org/10.1016/j.micinf.2018.04.001

March, C., Cano, V., Moranta, D., Llobet, E., Pérez-Gutiérrez, C., Tomás, J. M., Suárez, T., Garmendia, J., & Bengoechea, J. A. (2013). Role of bacterial surface structures on the interaction of Klebsiella pneumoniae with phagocytes. PloS one, 8(2), e56847. https://doi.org/10.1371/journal.pone.0056847

Rice L. B. (2008). Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. The Journal of infectious diseases, 197(8), 1079–1081. https://doi.org/10.1086/533452

Szijártó, V., Nagy, G., Guachalla, L., Nagy, E., Rollenske, T., & Wardemann, H. (2018). Anti-galactan II monoclonal antibodies targeting Klebsiella pneumoniae. Arsanis Biosciences GmbH. https://lens.org/032-377-400-460-331

Downloads

Published

2024-12-17

Section

Article

How to Cite

1.
Bourbon A. AI516 and AI523 antibodies recognize the O-antigen of K. pneumoniae KpGE strain by western blot. Antib. Rep. [Internet]. 2024 Dec. 17 [cited 2024 Dec. 21];7(1):e1722. Available from: https://oap.unige.ch/journals/abrep/article/view/1722